Stanislav Glezer - May 10, 2022 Form 4 Insider Report for Inogen Inc (INGN)

Role
EVP, Chief Medical Officer
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
May 10, 2022
Transactions value $
$0
Form type
4
Date filed
5/12/2022, 06:24 PM
Previous filing
Mar 3, 2022
Next filing
Sep 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Award $0 +32.6K $0.00 32.6K May 10, 2022 Common Stock 32.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2 Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024.